Xenon Pharmaceuticals (XENE)

• Market cap: $2.35B
• 1 day: -8.67%
• 5 days: -12.03%
• 1 month: -14.39%
• 3 months: -23.72%
• 6 months: -24.12%
• Year to date: -23.72%
• 1 year: -27.29%
• 5 years: 200.10%
• 10 years: 78.87%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

5,216% more call options, than puts

Call options by funds: $4.36M | Put options by funds: $82K

45% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 20

44% more funds holding in top 10

Funds holding in top 10: 9 [Q3] → 13 (+4) [Q4]

3% more funds holding

Funds holding: 201 [Q3] → 208 (+7) [Q4]

0% more capital invested

Capital invested by funds: $2.99B [Q3] → $2.99B (+$2.93M) [Q4]

0.04% less ownership

Funds ownership: 100.11% [Q3] → 100.06% (-0.04%) [Q4]

9% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 70

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $53 73% upside
• Avg. target: $60 96% upside
• High target: $67 119% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Douglas Tsao 23% 1-year accuracy 39 / 171 met price target	73% upside $53	Buy Reiterated	24 Feb 2025
Deutsche Bank David Hoang 35% 1-year accuracy 6 / 17 met price target	119% upside $67	Buy Initiated	11 Feb 2025